NeuroLux offers the only wireless optogenetics device platform that is fully-implantable, ultralightweight, and battery-free. These systems dramatically improve and simplify the means for light delivery and control in optogenetics experiments, thereby catalyzing the further adoption of these methodologies by the neuroscience community. This workshop will provide attendees the opportunity to...
Latest Development of an Upcoming Addition to Our Product Portfolio Published in PNAS!
Wireless optogenetics technology for neuroscience research has assisted the neuroscience community in controlling neural activation and silencing and catalyzed a desire for powerful synergistic tools. One of the latest advancement in complementary toolsets is the creation of fiber photometry, with capability to optically record neural activity. The currently-available tethered approach...
Anthony Banks is Guest Speaker at University of Illinois Office of Technology Management’s Share the Vision 2017
Anthony Banks, one of the co-founders and the vice president of NeuroLux, Inc., will deliver a talk on innovative discovery tools for medical research as one of the guest speakers for Share the Vision 2017 on September 21, 2017, at the EnterpriseWorks Startup Incubator. The event is a startup showcase...
NeuroLux awarded NIH STTR Phase I Grant
NeuroLux, an early stage biotech company based in Champaign, IL, has been awarded a Small Business Technology Transfer (STTR) Phase I grant by the National Institutes of Health (NIH) to develop wireless, battery-free devices for programmable fluid delivery and optogenetic stimulation, in designs fully compatible with the existing NeuroLux HF...